NCT00121979View on ClinicalTrials.gov

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

March 31, 2006

Conditions
HIV Infections
Interventions
DRUG

Racivir, a non-nucleoside reverse transcriptase inhibitor

Trial Locations (6)

10461

Jacobi Medical Center, The Bronx

14000

Instituto Nacional de Nutricion, Mexico City

29206

Burnside Clinic, Columbia

60611

Northwestern University, Chicago

C1202ABB

Fundacion Huesped Clinical Research, Buenos Aires

Unknown

Medical Research Center Consultorio Royal Center, Republico de Panama

Sponsors

Lead Sponsor

Pharmasset
All Listed Sponsors
lead

Pharmasset

INDUSTRY

NCT00121979 - Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects | Biotech Hunter | Biotech Hunter